nuevo numero de diciembre del Australian Prescriber

Estimadas y estimados,


Esta disponible el nuevo numero de diciembre del Australian Prescriber en:

http://www.australianprescriber.com/upload/pdf/issues/161.pdf

con el siguiente Contenido:

The prescribing cascade. Kalisch LM, Caughey GE, Roughead ER, Gilbert AL

Appropriate primary prevention of cardiovascular disease: does this mean more or less statin use? Smith J

Abnormal laboratory results: Prostate specific antigen. Sikaris K

Alkalinisation of local anaesthetic solutions. Brandis K

New drugs for osteoporosis. Ebeling PR

Deprescribing. Le Couteur D, Banks E, Gnjidic D, McLachlan A


Plus features
Top 10 drugs

Letters to the Editor

Medicines Safety Update
http://www.australianprescriber.com/upload/pdf/articles/1240.pdf

* Proton pump inhibitors and acute interstitial nephritis
* Pradaxa (dabigatran) and the risk of bleeding
* Reducing the risk of myopathy and rhabdomyolysis with simvastatin –
new dosage recommendations and contraindications
* The risks of purchasing injectable cosmetic medications online


New drug reviews: nomegestrol/oestradiol
Medicines Australia Code of Conduct: breaches
Dental notes: Local anaesthetic solutions
Dental notes: New drugs for osteoporosis

WHO Pharmaceuticals Newsletter (No. 2, 2011)

Esta disponible el WHO Pharmaceuticals Newsletter (No. 2, 2011) con el siguiente contenido:

Regulatory Matters
Antipsychotics ........1
Buflomedil ............1
Dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists . 1
Dronedarone ........ 2
Lopinavir/ritonavir....... 3
Methylene blue injectable..... 3
Modafinil ..................... 4
Proton pump inhibitors.........4
Rosiglitazone ............. 5
Rotavirus vaccination........... 6
Sitaxentan ............ 6
Terbutaline........ 7
Topiramate........... 7

Safety of Medicines
Abacavir ............... 9
Colchicine ............. 9
Daptomycin........... 9
Dronedarone ..........10
H1N1 influenza vaccine (Pandemrix).................. 10
Lenalidomide .............11
Natalizumab ............12
Omalizumab ............................... 12
Seasonal influenza vaccine ............... 12

Feature
WHO Training Course on Pharmacovigilance ............. 14

proximamente disponible en:
http://www.who.int/medicines/publications/newsletter/en/index.html